Reitsma, P.H

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet

Blood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and Management

Cited by 1,063

High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor

Rietveld, I. M., Lijfering, W. M., le Cessie, S., Bos, M. H. A., Rosendaal, F. R., Reitsma, P. H., & Cannegieter, S. C. (2019) · Journal of Thrombosis and Haemostasis

Blood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and Management

Cited by 154

Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation

Slofstra, S. H., Bijlsma, M. F., Groot, A. P., Reitsma, P. H., Lindhout, T., ten Cate, H., & Spek, C. A. (2007) · Blood

Blood Coagulation and Thrombosis MechanismsTrauma, Hemostasis, Coagulopathy, Resuscitation

Cited by 66

High levels of protein C are determined by PROCR haplotype 3

PINTAO, M. C., ROSHANI, S., DE VISSER, M. C. H., TIEKEN, C., TANCK, M. W. T., WICHERS, I. M., MEIJERS, J. C. M., ROSENDAAL, F. R., MIDDELDORP, S., & REITSMA, P. H. (2011) · Journal of Thrombosis and Haemostasis

Blood Coagulation and Thrombosis MechanismsComplement system in diseases

Cited by 16